Raffit Hassan

14.9k citations
174 papers · 11.9k · 4 hit papers · h-index 57

Impact in

  • Biotechnology top 0.05%
    • Cancer Research and Treatments
  • Oncology top 0.5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Occupational and environmental lung diseases 111
    • Pleural and Pulmonary Diseases 31
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 13
    • Medical Imaging and Pathology Studies 12
    • Cancer Research and Treatments 21
    • Microbial Inactivation Methods 12

Raffit Hassan

169 papers receiving 11.6k citations

Raffit Hassan's Hit Papers

Treatment of Pleural Mesothelioma: ASCO Guideline Update 2025 · 28 citations
280+5+11Years since publication200400600

Peers

Raffit Hassan
Comparison fields: 5 of 119
  • Biotechnology 2.2k
  • Oncology 4.2k
  • Immunology 3.3k
  • Pulmonary and Respiratory Medicine 4.4k
  • Radiology, Nuclear Medicine and Imaging 1.5k
Replace Mitchell Ho with:
Mitchell Ho United States
James W. Hodge United States
Richard Lake Australia
Kenneth A. Foon United States
Alexander K. Knuth Germany
Neil N. Senzer United States
Jon M. Wigginton United States
Alfons J.M. van den Eertwegh Netherlands
Patrizia Nanni Italy
Zenon Steplewski United States
Raffit Hassan relative to Mitchell Ho United States Mitchell Ho's profile →
Citations per field
00.5×2×3×4.1×
Mitchell Ho · 1×
Citations per year

Countries citing papers authored by Raffit Hassan

Since Specialization
Citations

This map shows the geographic impact of Raffit Hassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffit Hassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffit Hassan more than expected).

Fields of papers citing papers by Raffit Hassan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffit Hassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffit Hassan. The network helps show where Raffit Hassan may publish in the future.

Co-authors

The 25 scholars most cited alongside Raffit Hassan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raffit Hassan Line = papers co-authored together Raffit Hassan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Hit paper breakdown →
2009745
2
Antibody–drug conjugates for cancer therapy
Hit paper breakdown →
2016506
3 2006443
4 2004395
5 2007342
6 2011322
7
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Hit paper breakdown →
2018313
8 2006307
9 2007289
10 2016277
11 2006238
12 2014216
13 2012202
14 2013195
15 2009194
16 2005193
17 2010172
18
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.
2007162
19 2008161
20 2015160

About Raffit Hassan

Raffit Hassan is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology, Oncology, Immunology and Neurology, having authored 174 papers that have together received 11.9k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (111 papers), Pleural and Pulmonary Diseases (31 papers), Cancer Research and Treatments (21 papers), Toxin Mechanisms and Immunotoxins (18 papers), CAR-T cell therapy research (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Medical Imaging and Pathology Studies (12 papers) and Microbial Inactivation Methods (12 papers). The work is most often cited by research in Biotechnology (2.2k citations), Oncology (4.2k citations), Immunology (3.3k citations), Pulmonary and Respiratory Medicine (4.4k citations) and Radiology, Nuclear Medicine and Imaging (1.5k citations). Raffit Hassan has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ira H Pastan, Anish Thomas, Robert J. Kreitman, Mitchell Ho, Tapan Kumar Bera, Jingli Zhang, Beverly A. Teicher, Masanori Onda, David J. FitzGerald and Christine Campo Alewine. Their work appears in journals such as Clinical Cancer Research, Journal of Thoracic Oncology, Proceedings of the National Academy of Sciences, Lung Cancer and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact